Literature DB >> 32100209

Cardiovascular Volume Reserve in Patients with Heart Failure and Reduced Ejection Fraction.

Petra Nijst1,2, Pieter Martens3, Frederik H Verbrugge3, Matthias Dupont3, W H Wilson Tang4, Wilfried Mullens3,5.   

Abstract

This study aimed to investigate the relationship between intravascular volume and intracardiac filling pressures in stable HF patients with reduced ejection fraction (HFrEF). A total of 40 HFrEF patients (LVEF 36 ± 10%) (10 subjects with a pulmonary artery catheter) underwent intravascular volume expansion with 1 L hydroxyl-ethyl-starch over 3 h with coinciding intravascular volume measurements (technetium (99 tc)-labeled red blood cell technique). Intravascular blood volume increased from 5.0 ± 1.0 L to 5.7 ± 1.0 L (p < 0.0001). No change in clinical status, echocardiographic indices, or cardiac filling pressures was noticed. Invasively measured right atrial pressure and pulmonary arterial wedge pressure increased significantly immediately after start of infusion (4 ± 2 mmHg to 8 ± 4 mmHg; p = 0.01 and 10 ± 3 mmHg to 15 ± 6 mmHg; p = 0.01, respectively), decreased afterwards, and remained stable for 3 h (6 ± 2 mmHg and 14 ± 4 mmHg, respectively). The accuracy of cardiac filling pressure estimates to predict intravascular volume expansion was low (all AUC < 0.65).

Entities:  

Keywords:  Central venous pressure; Congestion; Echocardiography; Plasma volume; Pulmonary wedge pressure; Systolic heart failure

Year:  2020        PMID: 32100209     DOI: 10.1007/s12265-020-09973-8

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN: 1937-5387            Impact factor:   4.132


  1 in total

1.  Harnessing the Plasma Proteome to Mirror Current and Predict Future Cardiac Remodeling After Myocardial Infarction.

Authors:  Upendra Chalise; Mediha Becirovic-Agic; Jocelyn R Rodriguez-Paar; Shelby R Konfrst; Sharon D B de Morais; Catherine S Johnson; Elizabeth R Flynn; Michael E Hall; Daniel R Anderson; Leah M Cook; Kristine Y DeLeon-Pennell; Merry L Lindsey
Journal:  J Cardiovasc Transl Res       Date:  2022-10-05       Impact factor: 3.216

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.